FDA, Supreme Court

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis), an oral transthyretin (TTR) ...
A clinical trial study will give vets medical and commercial-grade cannabis products to look at “real-world” use and its ...
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
On November 7, 2024, the FDA announced that it is proposing to remove oral phenylephrine as a drug that is permitted for use ...
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...
A new TikTok trend involving taking honey packets before sex has prompted the Food and Drug Administration to issue a warning ...